Filing Flows › Comparisons › OABI vs BIAF
OmniAb vs bioAffinity Technologies: OABI and BIAF compared
OmniAb is the larger company: $4.0M of revenue in its latest quarter (Q3 2026) against $1.1M for bioAffinity Technologies (Q3 2026). OmniAb is growing faster (+78% against -26% a year earlier). bioAffinity Technologies is more profitable, with an operating margin of -328.0% against -409.9%.
Where the money goes: OABI and BIAF
OmniAb (OABI) · Q3 2026
OmniAb, Q3 2026: revenue $4.0M (+78% year over year), operating margin -409.9%, net loss $15.7M, operating cash flow $10.6M. The chart follows the revenue to costs, profit and cash.
bioAffinity Technologies (BIAF) · Q3 2026
bioAffinity Technologies, Q3 2026: revenue $1.1M (-26% year over year), operating margin -328.0%, net loss $5.3M, operating cash flow −$3.9M. The chart follows the revenue to costs, profit and cash.
| OmniAb (OABI) | bioAffinity Technologies (BIAF) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $4.0M | $1.1M |
| Revenue growth, Y/Y | +78% | -26% |
| Operating margin | -409.9% | -328.0% |
| Net earnings | −$15.7M | −$5.3M |
| Net margin | -393.9% | -493.1% |
| Operating cash flow | $10.6M | −$3.9M |
Where the revenue comes from
OmniAb
- Service revenue: $2.8M (71%)
- xPloration revenue: $703K (18%)
- Royalty revenue: $355K (9%)
- License and milestone revenue: $100K (3%)
bioAffinity Technologies
- Health Care, Patient Service: $863K (81%)
- Histology Service Fees: $190K (18%)
- Medical Director Fees: $17K (2%)
Questions
Which is bigger, OmniAb or bioAffinity Technologies?
OmniAb is the larger company: $4.0M of revenue in its latest quarter (Q3 2026) against $1.1M for bioAffinity Technologies (Q3 2026).
Is OmniAb or bioAffinity Technologies growing faster?
OmniAb is growing faster (+78% against -26% a year earlier).
Which is more profitable, OmniAb or bioAffinity Technologies?
bioAffinity Technologies is more profitable, with an operating margin of -328.0% against -409.9%.
More: OmniAb earnings · how OmniAb makes money · bioAffinity Technologies earnings · how bioAffinity Technologies makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 30, 2026; 10-Q filed Nov 6, 2026). Fiscal quarters can end on different dates. Not investment advice.